BACKGROUND: Long-term complication and reoperation rates in 1,211 patients undergoing TURP for symptomatic BPH between 1988 and 1991 were evaluated after a follow-up of at least 10 years. METHODS: Of the 1,211 patients who underwent TURP, 577 (47.6%) were available for follow-up. Long-term complications as well as reoperation rates were evaluated on the basis of a patient questionnaire or a physician interview. RESULTS: Repeat operation had to be performed in 35 patients (6%). TUR for bladder neck contracture had to be done in 14 patients (2.4%), while repeat TURP for BPH obstruction was required in 11 patients (1.9%). Finally, urethral strictures mandating surgical correction were present in 10 patients (1.7%). CONCLUSIONS: TURP is associated with low reoperation rates and therefore remains the gold standard in BPH therapy. Nevertheless, follow-up of these patients must be continued, as late complications requiring intervention may occur even after 10 years postoperatively. Copyright 2003 Wiley-Liss, Inc.
BACKGROUND: Long-term complication and reoperation rates in 1,211 patients undergoing TURP for symptomatic BPH between 1988 and 1991 were evaluated after a follow-up of at least 10 years. METHODS: Of the 1,211 patients who underwent TURP, 577 (47.6%) were available for follow-up. Long-term complications as well as reoperation rates were evaluated on the basis of a patient questionnaire or a physician interview. RESULTS: Repeat operation had to be performed in 35 patients (6%). TUR for bladder neck contracture had to be done in 14 patients (2.4%), while repeat TURP for BPH obstruction was required in 11 patients (1.9%). Finally, urethral strictures mandating surgical correction were present in 10 patients (1.7%). CONCLUSIONS: TURP is associated with low reoperation rates and therefore remains the gold standard in BPH therapy. Nevertheless, follow-up of these patients must be continued, as late complications requiring intervention may occur even after 10 years postoperatively. Copyright 2003 Wiley-Liss, Inc.
Authors: T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner Journal: Urologe A Date: 2016-02 Impact factor: 0.639
Authors: R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn Journal: Urologe A Date: 2009-12 Impact factor: 0.639